Western blot analysis confirmed that LPA treatment significantly increased AKT and endothelial nitric oxide (eNOS) phosphorylation, and GPR87 overexpression further increased the effect of LPA treatment in A549 lung cancer cells (Figure 3b,c and Figure S3b). This evidence concerns the gene AKT1 and lung cancer.